Antimicrobial susceptibility testing standards driving clinical decisionmaking have centered around the use of cation-adjusted Mueller-Hinton broth (CA-MHB) as the medium with the notion of supporting bacterial growth, without consideration of recapitulating the in vivo environment. However, it is increasingly recognized that various medium conditions have tremendous influence on antimicrobial activity, which in turn may have major implications on the ability of in vitro susceptibility assays to predict antibiotic activity in vivo. To elucidate differential growth optimization and antibiotic resistance mechanisms, adaptive laboratory evolution was performed in the presence or absence of the antibiotic nafcillin with methicillin-resistant Staphylococcus aureus (MRSA) TCH1516 in either (i) CA-MHB, a traditional bacteriological nutritionally rich medium, or (ii) Roswell Park Memorial Institute (RPMI), a medium more reflective of the in vivo host environment. Medium adaptation analysis showed an increase in growth rate in RPMI, but not CA-MHB, with mutations in apt, adenine phosphoribosyltransferase, and the manganese transporter subunit, mntA, occurring reproducibly in parallel replicate evolutions. The medium-adapted strains showed no virulence attenuation. Continuous exposure of medium-adapted strains to increasing concentrations of nafcillin led to mediumspecific evolutionary strategies. Key reproducibly occurring mutations were specific for nafcillin adaptation in each medium type and did not confer resistance in the other medium environment. Only the vraRST operon, a regulator of membrane-and cell wall-related genes, showed mutations in both CA-MHB-and RPMI-evolved strains. Collectively, these results demonstrate the medium-specific genetic adaptive responses of MRSA and establish adaptive laboratory evolution as a platform to study clinically relevant resistance mechanisms. IMPORTANCE The ability of pathogens such as Staphylococcus aureus to evolve resistance to antibiotics used in the treatment of infections has been an important concern in the last decades. Resistant acquisition usually translates into treatment failure and puts patients at risk of unfavorable outcomes. Furthermore, the laboratory testing of antibiotic resistance does not account for the different environment the bacteria experiences within the human body, leading to results that do not translate into the clinic. In this study, we forced methicillin-resistant S. aureus to develop nafcillin resistance in two different environments, a laboratory environment and a physiologically more relevant environment. This allowed us to identify genetic changes that led to nafcillin resistance under both conditions. We concluded that not only does the environment dictate the evolutionary strategy of S. aureus to nafcillin but also that the evolutionary strategy is specific to that given environment.
RESULTS
Laboratory evolution for adaptation to medium environments. S. aureus TCH1516 was forced to evolve under two medium conditions to understand how it adapts under growth rate selection to different nutritional environments. The two chosen medium types were CA-MHB and RPMI ϩ 10%LB (referred to as RPMIϩ), since differential susceptibility to nafcillin was observed across both conditions (see Table S1 in the supplemental material) (11) . Five independent populations of S. aureus TCH1516 were forced to evolve on CA-MHB, while eight independent populations were forced to evolve on RPMIϩ for an average of 108 and 100 batch flask transfers, respectively (Table S2 ). Flask transfers were performed when an optical density at 600 nm (OD 600 ) of 0.3 Ϯ 0.02 or 0.434 g (dry weight [DW])/liter was achieved to prevent the cells from entering stationary phase, thus selecting for advantages in growth rate. Although no growth rate improvements were observed for evolutions performed in CA-MHB, population growth rates for S. aureus on RPMIϩ increased from a starting wild-type growth rate of 0.75 Ϯ 0.1 h Ϫ1 to 1.1 Ϯ 0.1 h Ϫ1 , an ϳ1.5-fold increase, during a range of 4.52 ϫ 10 12 to 5.26 ϫ 10 12 cumulative cell cycle divisions (CCD) ( Fig. 1A and B ). CCD has previously been shown to effectively represent the time scale for ALEs in contrast to elapsed time or generations (25) . It should be noted that the overall growth rate of the population at the end of the evolution on RPMIϩ (1.06 Ϯ 0.10 h Ϫ1 ) was similar to that of the starting growth rate on CA-MHB (1.12 Ϯ 0.083 h h Ϫ1 ) (Table S2 ). Clonal isolates were selected from each of the final flasks of the independently evolved populations of the medium adaptation ALEs (i.e., endpoint clones) to RPMIϩ (eight clones) and CA-MHB (five clones) in order to explore the phenotypes from the isolated evolved genotypes. Growth rates were measured for each of the endpoint clones, and there was concordance between the values observed for the populations at the end of the evolutions. The increase in growth rate of S. aureus TCH1516 through adaptation to RPMIϩ, but not to CA-MHB, was confirmed on the clonal level. Similar work has been performed forcing S. aureus to evolve in various medium conditions, although growth rates were not reported (26, 27) . The identical growth rate between the two conditions evaluated here indicates an apparent maximum achievable growth rate for strain TCH1516 in a batch growth rich medium environment, given the stated evolution times. Following medium adaptation, the medium-adapted strains were evaluated for their virulence capabilities and sequenced to explore the genetic mechanisms behind observed fitness improvements.
Medium-adapted strain virulence in a murine model of pneumonia. Continued passaging of pathogenic strains of bacteria in vitro can lead to attenuation, yielding derived laboratory strains that are disparate to those seen within patients (28) . As multiple dedicated pathways are essential for virulence within a host, it is often the case that laboratory-evolved strains become nonpathogenic, due to the disruption of those pathways, leading to attenuation, therefore decreasing their clinical relevance. A murine pneumonia infection model was used to examine the virulence of mediumadapted strains in comparison to the pathogenic TCH1516 parental lineage. This model utilizes an intratracheal injection to establish a bacterial pneumonia and has been previously used to assess lung bacterial burdens (29) . Surprisingly, despite RPMIϩ serving as a better mimic for physiological conditions, strains that were adapted to RPMIϩ did not have a virulence advantage within the host compared to those adapted to the standard laboratory growth medium (Fig. 1C ). It was determined that mediumadapted strains maintain their pathogenicity and had no gross virulence defects in comparison with the TCH1516 parental lineage, indicating that these strains were not attenuated.
Mutation analysis of whole-genome resequencing for medium adaptation. Whole-genome sequencing was performed on evolved populations and selected clones from the ALE experiments on the two selected medium types to explore whether mutations could be linked to the observed fitness improvements. Sequences were analyzed to determine mutations from the multiple replicates under each con-dition (30, 31) . For the CA-MHB condition, only endpoint clones were sequenced given the lack of an apparent fitness change during the course of the evolution, and a total of three unique mutations were found across all five replicates (two clones had no mutations detected [Table S3 ]). For the RPMIϩ condition, there were 261 unique (Table S4 ). To focus the analysis, mutations were labeled as "key mutations" if a gene or genetic region contained multiple unique mutations across replicates or if an identical mutation appeared across independent ALE replicates. For RPMIϩ, there were eight genes or genetic regions that met these criteria, with three having greater than two instances. A summary of the RPMIϩ medium adaptive mutations is shown in Table 1 . For CA-MHB, there was no gene which shared mutations across two of the endpoint clones. In RPMIϩ medium conditions, the most prevalent gene that mutated was apt, with all independent replicates containing at least one mutation in this gene, which remained present in the majority of endpoint clones ( Table 1 ). The apt gene encodes an adenine phosphoribosyltransferase which enables nucleotide salvage reactions converting adenine to AMP (32) . Mutations in this gene have also been discovered after in vitro passaging of S. aureus after exposure to increasing concentrations of vancomycin (18) . Constructed apt deletion mutants experienced significant reduction in extracellular DNA (eDNA) release, a major constituent for biofilm stability and formation, low production of extra polymeric substances (33, 34), as well as increased resistance to Congo red (35) . An additional highly mutated region for growth rate optimization on RMPIϩ was the mntA gene and its intergenic region upstream of both mntA and its regulator mntR. The mntA gene encodes a manganese permease subunit of an ATP binding transporter, while mntR encodes a metal-dependent transcriptional regulator (36) . An identical mutation was identified in the start codon of mntA across three independent ALEs, modifying the initiation site from a suboptimal form (UUG) to AUG, which is the optimal start codon in prokaryotes (37, 38) . Mutations in the intergenic region include two single nucleotide polymorphisms (SNPs) occurring 1 and 2 nucleotides upstream of mntA, likely affecting its promoter. The other intergenic change was an insertion of a 20-nucleotide sequence, 43 bp upstream of mntA. Acquisition of manganese is important for cell survival and replication of pathogens and is crucial for cell detoxification of reactive oxygen species (39) . Inactivation of the MntABC transporter complex in another USA300 strain has been shown to attenuate virulence in in vivo mouse models (40) . Manganese acquisition appears to be particularly relevant in endovascular infections. Disruption of mntA, mntH, mntR, or both mntA and mntH also significantly reduces intracellular survival in human endothelial cells. Bioavailable Mn is utilized by S. aureus to detoxify reactive oxygen species and protect against neutrophil killing, enhancing the ability to cause endocardial infections (41, 42) .
Additional key mutations were identified in the RPMIϩ growth rate adaptation: mutations in two genes encoding regulatory proteins, cspA and stk1, and in the dynA, recJ, and lyrA genes, encoding a GTPase, an exonuclease, and a protease, respectively ( Table 1 ; see also Text S1 in the supplemental material).
The medium-adapted strains were subsequently used to understand S. aureus' tolerization to nafcillin, with the goal of identifying the genetic basis of this process in the different medium environments.
Laboratory evolution for adaptation to nafcillin tolerance. A tolerance adaptive laboratory evolution (TALE) experiment was implemented to force medium-adapted strains of S. aureus TCH1516 to develop resistance to the ␤-lactam antibiotic nafcillin and identify mutations enabling an elevated growth rate under increasing antibiotic stress concentrations in both CA-MHB and RPMIϩ medium environments. The S. aureus strains selected as starting strains of the TALE experiments consisted of the respective medium-adapted strains, denoted STM (CA-MHB) and STR (RPMIϩ). The starting strains for the TALE experiments were medium-adapted strains with distinct genotypes (Table 2). TALE proved to be effective in developing strains with increased resistance to nafcillin in both RPMIϩ and CA-MHB. Three medium-adapted starting strains per medium type (STM 1, 2, and 3 and STR 1, 4, and 5) were forced to evolve in duplicate or triplicate to generate a total of 14 independent evolutions ( Table 2 ). Figure 2A details a typical TALE trajectory of the growth rate and the continuously increasing concentration of nafcillin in RPMIϩ ( Fig. S1 shows a CA-MHB nafcillin typical TALE trajectory). Over the course of evolution, S. aureus populations underwent an average of 3.93 ϫ 10 12 CCD and 72 flasks for CA-MHB and 13.81 ϫ 10 12 CCs and 175 flasks for RPMIϩ. Evolutions on RPMIϩ were noticeably longer ( Table 2 ) due to the differential susceptibility of S. aureus TCH1516 to nafcillin in the two medium conditions (11) ( Table S1 ). The MIC on RPMIϩ was ϳ100-fold less compared to the MIC on CA-MHB for the respective starting strains (Table S5 ). The initial starting concentrations of nafcillin for the TALEs were therefore adjusted to ensure cell viability. Concentrations of nafcillin reached as high as 600ϫ MIC 90 on RPMIϩ and 8ϫ MIC 90 on CA-MHB (Table 2) compared to the wild type on their respective medium.
Endpoint clonal isolates from each of the independent TALE replicates were selected to assess and confirm the increased nafcillin resistance phenotype. As expected, nafcillin resistance for the evolved clones was increased. However, the increase in tolerance observed for isolated clones did not quantitatively match the values tolerated by the TALE populations from which they were isolated (Fig. 2B ). In RPMIϩ, an MIC 90 ranging from 10 to 20 g/ml was achieved for isolated clones compared to a range of 45 to 83 g/ml observed in population endpoints. The same phenomenon was observed in a smaller degree for isolated clones from the TALE in CA-MHB. The MIC 90 of nafcillin for CA-MHB TALE isolates ranged between 31.3 and 50 g/ml compared to 61 to 87 g/ml measured for TALE final evolved populations ( Fig. 2B and Table 2 ). This can likely be attributed to population dynamics, kin selection (43), "bacterial cheating," where overproduction of degradative enzymes can inactivate antibiotic molecules (44), or simply due to a difference in culturing methods under which the clonal MICs were determined compared to the culturing conditions during the TALE experiment (see Materials and Methods).
To assess phenotypic trade-offs in the evolved strains, endpoint clonal growth rates were measured in their evolutionary medium as well as the alternate medium type utilized in this study (i.e., a medium swap) under no nafcillin stress. Characterizations were performed with both medium-and nafcillin-adapted clones. As shown above ( Fig. 1B) , RPMIϩ medium-adapted strains (STR) saw a 52% increase in growth rate compared to the wild-type S. aureus TCH1516 (two-way analysis of variance [ANOVA], P Ͻ 0.0001) (Table S6 ). Medium adaptation to CA-MHB (STM) did not confer a fitness advantage in RPMIϩ (two-way ANOVA, P ϭ 0.8745). Strains with a higher resistance to nafcillin in RPMIϩ (SNFR) resulted in a fitness tradeoff compared to medium-adapted strains in the same medium (STR) with an overall 11% decrease in growth rate (two-way ANOVA, P ϭ 0.0054) ( Fig. 3A and Table S6 ). For the medium swap conditions, there was an unexpected growth rate increase of 29% for strains evolved for resistance to nafcillin in CA-MHB (SNFM) when grown in RPMIϩ compared to the progenitor strains that were adapted to CA-MHB (STM) (two-way ANOVA, P Ͻ 0.0001) ( Fig. 3A and Table S6 ). There were no significant changes in growth rates observed across any of the strains analyzed in CA-MHB medium (Table S6) .
Mutational analysis for tolerance evolutions. Whole-genome sequencing was performed on evolved populations and selected clones from TALEs on both medium types to determine shared or unique mutational mechanisms of nafcillin resistance phenotypes. Key mutations were again identified in a similar manner to those from the medium adaptation ALEs (i.e., if the gene or genetic region contained multiple unique mutations or the same mutation across independent ALE replicates). On average, there were fewer mutations in response to nafcillin stress on CA-MHB compared to RPMIϩ, as represented by the key mutations in the endpoint clones and populations (Tables 3  and 4 ). Endpoint clones and populations from evolution experiments on CA-MHB led to the identification of 13 unique key mutations across 5 genes, while the ones performed on RPMIϩ presented 25 unique key mutations across 10 genes (Tables 3 and 4 ).
In CA-MHB, the majority of key mutations had been previously identified as being related to a resistance phenotype. One of the most frequently mutated gene sets were those that encoded the regulatory system VraSRT. In fact, vraT is a negative regulator of the vraSR operon which controls transcription of a number of genetic determinants involved in cell wall synthesis and cell division (45) . Five of the 13 total key mutations under this condition were SNPs in the genes of this system. This regulatory system has also been shown to be mutated under vancomycin selection pressure in a different USA300 S. aureus strain, which also decreased daptomycin susceptibility (46) . Another mutated gene was apt, which also occurred in RPMIϩ medium adaptation ALE. This is interesting, as this might be the reason why SNFM clones presented an improved growth rate in RPMIϩ conditions (Fig. 3A) . As discussed earlier, apt enables nucleotide salvage reactions, a much more energetically favorable pathway than de novo nucleotide synthesis (47) , and it has been implicated in the stringent response of bacteria to stressful conditions (32, 48) . Mutations resulting in an amino acid substitution and a premature stop codon were discovered in pbuG, which encodes a guanine/xanthine permease. A Bacillus subtilis mutant with defects in pbuG displayed impaired uptake rates of nucleoside sugars guanine and hypoxanthine as well as resistance to toxic purine analog compounds (49) . There has also been evidence to suggest a role between purine biosynthesis and increased resistance to vancomycin and daptomycin, two other membrane-and cell wall-targeting antibiotics (50, 51) . The last key mutated gene that saw multiple mutations across TALE replicates in CA-MHB was mgt, or sgtB referred to elsewhere, whose gene product is a monofunctional glycosyltransferase responsible for elongation of the glycan strands using lipid-linked disaccharidepentapeptide as the substrate (52) . Each of the mutations in sgtB seems to lead to open reading frame disruption (Table 3) , possibly abolishing its transcription. This glycosyltransferase is nonessential in S. aureus (53) (54) (55) (56) , but it seems to be upregulated upon treatment with cell wall-targeting antibiotics, including oxacillin (57) . Furthermore, inactivation of sgtB in the USA300 S. aureus LAC strain has demonstrated increased resistance to several cell wall antibiotics (58) . In RPMIϩ, although there was a higher number of mutations, there was also a higher degree of parallelism, with 36% of key mutations compared to 25.5% in CA-MHB. The most targeted gene for mutation upon exposure to nafcillin in RPMIϩ was mecA ( Table 4 ). Mutations in mecA occurred in seven independent lineages, with an SNP at position 586 changing an aspartic acid residue to a tyrosine residue, comprising six of these mutations. Penicillin binding protein 2a (PBP2a) is encoded by mecA and is responsible for catalyzing transpeptidation of peptidoglycan during cell wall synthesis. The binding protein has long been thought to play a vital role in resistance to ␤-lactamase-resistant semisynthetic ␤-lactams (nafcillin, oxacillin, methicillin, etc.) due to its lower affinity for these antibiotics (59, 60) . Emergence of S. aureus strains containing mecA has been hypothesized to be due in part to horizontal gene transfer from closely related staphylococcal species leading to formation of MRSA precursors (61) . It has been discovered that PBP2a is essential for S. aureus survival, although it is able to replace transpeptidation activity by other PBPs, it still requires interaction with the transglycosylase activity of PBP2a (62) .
Another highly mutated gene was oatA, which encodes an O-acetyltransferase. Genetic changes included formation of a premature stop codon, in-frame deletion of 12 bp, and two single base pair deletions. OatA encodes the enzyme required for a The gene nomenclature provided by prokka annotation, reflected in the mutation analysis, is shown in the parentheses. The gene locus tag corresponds to USA300HOU_RSXXXXX. b An asterisk indicates that a mutation led to a stop codon being formed.
O-acetylation of peptidoglycan by translocation of acetyl groups from a cytoplasmic source across the membrane (61) . These results are consistent with previous data showing that exposure of MRSA to methicillin results not only in reduced peptidoglycan cross-linking but also in reduced peptidoglycan O-acetylation (63) . O-acetylation is important for resisting autolysis activity from lysozymes (64) and has been shown to increase susceptibility to certain ␤-lactams (65) . Reduction in O-acetylation has great implications for the host-pathogen relationship in S. aureus infections. Strains with mutations in O-acetyltransferase are more effectively killed by macrophages (66) . Furthermore, S. aureus oat mutants have been shown to release more interleukin 1␤ (IL-1␤) (66), a critical factor in rapid clearance of S. aureus bacteremia, as shown by the fact that patients with persistent bacteremia on antimicrobial therapy fail to mount a robust IL-1␤ response (67, 68) . In fact, beta-lactam therapy has been shown to elicit a more robust IL-1␤ response compared to vancomycin therapy in patients with S. aureus bacteremia to potentially explain, at least in part, the more favorable clinical and microbiological data of beta-lactams over vancomycin (69) . Coupled with previously cited phenotypic studies, our findings showing oat mutations induced by nafcillin selection pressure in physiological media on MRSA show direct evidence for a specific attenuation of virulence occurring at a genetic locus. These findings lend strong support of the role of nafcillin (and potentially other beta-lactams) as a potentially important adjunct therapy in MRSA bacteremia to enhance bacteremia clearance as previously reported (70) . Similar to what has been observed for the CA-MHB TALEs, the vraSRT system was also mutated, in this case mostly vraS, with a higher preference for amino acid position 66, where a valine was replaced by a leucine. As mentioned earlier, this operon controls transcription of a number of genetic determinants involved in cell wall synthesis and cell division (45) .
Two genes involved in regulating levels of cyclic diadenosine monophosphate (c-di-AMP) inside the cell were also mutated: gdpP, encoding a phosphodiesterase, and cdaA (also known as dacA), which encodes an adenylate cyclase. Both DacA and GdpP are involved in nucleotide signaling pathways, while the former produces c-di-AMP, the latter degrades the cyclic dinucleotide molecule (71, 72) . Studies suggest that SNP mutations in dacA, distinct from the ones presented here, affect methicillin resistance via nucleotide signaling by reducing c-di-AMP, resulting in faster growing, less resistant, and more virulent strains (73) . On the other hand, SNP mutations in gdpP have been observed in S. aureus after repeated exposure to oxacillin concentrations of 200ϫ MIC and insertional mutants revealed increased tolerance to both oxacillin and vancomycin, as well as altered phenotypic signatures (74, 75) . Also, clinical isolates from patients with S. aureus lacking mecA determinants were shown to have mutations in gdpP, further implicating the phosphodiesterase in resistance to ␤-lactams (76) . Other mutations included the following: ywtF, encoding a putative transcriptional regulator, belonging to a family of regulators associated with influencing virulence factors, antibiotic resistance, and cell envelope maintenance in various S. aureus species (77-79); codY, encoding a transcriptional regulator that acts as a repressor for more than 100 genes associated with branched-chain amino acid metabolism and virulence production under nutrient limiting conditions (80) (81) (82) ; rpoD, encoding a RNA polymerase subunit; ssaA2_4, encoding a secretory antigen precursor; and RS08710, encoding a heme uptake-related protein.
The overlap between mutations conferring resistance to nafcillin on the genetic level in both medium types was minimal. The key mutation overlap between the two TALE medium conditions was reduced to the vraSTR operon. As previously mentioned, mutations within this operon have previously been shown to increase expression of a cell wall stress stimulon leading to thicker cell wall and envelope (45, 83) . From all of the additional key mutations observed in CA-MHB nafcillin tolerized strains, pbuG and sgtB also occurred once in RPMIϩ nafcillin tolerized strains, in one replicate each (Table S7 ). On the other hand, from the other key mutations observed in nafcillin RPMIϩ tolerized strains, only the oatA gene was mutated once in one CA-MHB replicate (Table S8) . Interestingly, the genetic adaptation observed in the strains tolerized to nafcillin in RPMIϩ did not translate to a resistant phenotype in CA-MHB (Fig. 3B) , reiterating the medium-specific mechanisms employed toward nafcillin resistance. Nevertheless, the genes that were reproducibly mutated across the independent lineages under the CA-MHB and RPMIϩ conditions have, for the most part, been previously identified as being associated with an antibiotic resistance phenotype.
DISCUSSION
For decades, methicillin-resistant S. aureus (MRSA) has been one of the major contributors to community-and hospital-acquired infections with a broad repertoire of infection type, severity, and human hosts (84) . In the United States, this common commensal pathogen is responsible for more than 1 million cases of blood infection and close to 200,000 deaths (85) . With such alarming figures, it becomes imperative to understand the underlying mechanisms of antibiotic resistance and adaptation to the host environment. Here, we present a method for determining differential mechanisms of resistance on the genetic level under different medium environments utilizing adaptive laboratory evolution, whole-genome sequencing, and phenotypic characterizations of evolved strains. Genotypes of generated strains were characterized to study fundamental underlying differences in how environmental considerations affect susceptibility at a systems level. Insights gained by analyzing repeatedly mutated regions across different medium conditions in tandem with phenotypic assessment can be leveraged to inform more effective treatment strategies and identify novel drug targets. Thus, the major findings from this work include the following: (i) a significant growth rate increase via genetic adaptation to physiological medium (RPMIϩ) compared to a negligible one observed in CAMHB; (ii) no gross virulence attenuation observed in medium-adapted strains in a pneumonia model of infection; (iii) medium-specific adaptation toward nafcillin tolerance, attributed to parallely mutated genes, mostly related to membrane and cell wall integrity; (iv) key mutated genes previously shown to be associated with clinical resistant strains; (v) mutations in genetic loci under nafcillin selection pressure that could allow for enhanced intracellular survival. These findings support this approach to better understand clinically relevant adaptive strategies of bacteria that may influence not just antibiotic resistance, but also hostpathogen interactions.
Adaptive laboratory evolution was successful in generating medium-adapted strains of S. aureus TCH1516 to a more physiologically relevant medium, RPMIϩ. Strains adapted to RPMIϩ (STR) saw an increase in growth rate, while no such increase was observed in CA-MHB-adapted strains (STM) (Fig. 1B) . Mutations identified in RPMIϩadapted strains showed a high degree of evolutionary parallelism with mutations in the apt and mntA genes occurring in almost all of the independent ALE replicates ( Table 1) . Both gene products have been associated with the SOS stringent response in stressful conditions, while mntA specifically plays a key role in metal acquisition infection when the host limits availability (32, 39, 48, 86) . A recent transcriptome analysis has shown that S. aureus TCH1516 is under manganese starvation upon cultivation in RPMIϩ (96) , strengthening the argument of a transcription and translation optimization of the mnt operon in the RPMIϩ medium-adapted strains. Interestingly, mutations in apt, which enables nucleotide salvage reactions, were also identified in tolerance evolution to nafcillin, particularly when evolved on CA-MHB (Table 3 ). Mutations identified in this phosphoribosyltransferase likely play a crucial role in the improved growth rate in RPMIϩ in the presence of no antibiotic for medium-and nafcillin-adapted strains (Fig. 3A) .
The tolerance adaptive laboratory evolution (TALE) method proved successful in the generation of S. aureus TCH1516 strains resistant to nafcillin 2.5-to 4-fold higher compared to the wild type in CA-MHB and 80-to 160-fold higher in RPMIϩ ( Table 2 and Fig. 2B ) after continuous exponential growth in the presence of increasing concentrations of nafcillin. The overlap of shared mutations between nafcillin resistance in each medium type point to several previously studied targets for antibiotic resistance (45, 54, 83) . Evolution of antibiotic resistance in the tissue culture medium RPMI supplemented with 10% LB appears to enrich for several other mutations, particularly in mecA and other non-mecA genetic determinants (e.g., oatA and vraS). Mutations in mecA were all located in the active site of PBP2a (87) , suggesting an alteration in the target for nafcillin, and thus enabling transpeptidase activity to proceed. Mutations affecting synthesis and acquisition of branched-chain amino acids, as well as biosynthesis of peptidoglycan and its precursors potentially suggest a reorganization of metabolic activity more representative of host infection (71, 81, 88) . Importantly, mutations in oatA have been previously shown to have significant impact on S. aureus interaction with the host, potentially allowing enhanced intracellular survival to escape from largely extracellularly acting antibiotics like beta-lactams.
In summary, this study describes several mutations involved in adaptation to medium and nafcillin and discusses their possible role in those processes. These hypotheses warrant further investigation into the molecular mechanisms involved in such genetic adaptations, via reintroduction of such mutations into a wild-type strain using targeted genetic engineering approaches (89, 90) or biochemistry elucidation of protein activities and interactions. This study outlines specific mutations that can be tested via these approaches and provides strong contextual evidence of their causality. Furthermore, with a strain-agnostic approach, one could understand if these mutations are strain-specific or general adaptation mechanisms employed by S. aureus (91) .
MATERIALS AND METHODS
Adaptive laboratory evolution and tolerance evolution of S. aureus USA300_TCH1516. The adaptive laboratory evolution (ALE) experiment was begun by streaking the wild-type S. aureus USA300_TCH1516 (taxid 451516) on LB agar plates. Colonies (five for CA-MHB and eight for RPMIϩ) were then selected and grown overnight at 37°C in the appropriate medium. Each individual flask served as the starting point for independent ALE experiments. An automated liquid handling platform (92) was used to serially propagate the growing cultures and monitor growth rates. Each batch culture was grown in 15 ml of the respective medium at 37°C and well aerated with magnetic stirrers at 1,800 rpm. When the optical density (OD) reached a value of 0.3, 150 l was inoculated into the next flask, thus maintaining a continuous exponential growth. The automated system measured the OD at 600 nm (OD 600 ) algorithmically on a Tecan Sunrise Absorbance Microplate reader. When the optical density reached a value of 0.3 (Tecan Sunrise plate reader equivalent to an OD 600 of 1 on a traditional spectrophotometer with a 1-cm path length), 150 ul was inoculated into the next flask, thus maintaining a continuous exponential growth. The OD 600 values were converted to cell dry weight (DW) concentrations using a previously determined OD 600 -dry cell weight relationship for S. aureus (1.0 OD 600 ϭ 0.434 g DW/liter). Last, frozen stocks were taken intermittently throughout the course of the evolution experiments in 50% (vol/vol) glycerol solution and stored at -80°C. Tolerance evolution was performed similarly to medium adaptation as described above with the addition of continuously increasing concentration of nafcillin. The TALE method was adapted from the method in reference 93.
Growth rate calculations were determined and filtered if R 2 correlation was less than 0.98. Growth data were then smoothed to minimize noise following methods described in reference 94, by applying a three-median repeat smooth followed by convolution with a symmetrical kernel containing weights (1/4, 1/2, 1/4) and ended with final three-median smooth. Smoothed data were then fit to a piecewise cubic spline. The time scale of cumulative cell cycle divisions (CCD) was computed following methods outlined in reference 25.
MIC determination. Azithromycin (Fresenius Kabi), ceftazidime (Hospira), clindamycin (Pfizer), colistin (Xellia Pharmaceuticals ApS), daptomycin (Cubist Pharmaceuticals), linezolid (Pfizer), meropenem (Fresenius Kabi), and vancomycin (Mylan International) were purchased from a clinical pharmacy. Ampicillin, ciprofloxacin, gentamicin, and nafcillin were all purchased from Sigma-Aldrich. All drugs were resuspended in 1ϫ Dulbecco's phosphate-buffered saline (DPBS) (Corning).
The bacterial strains to be used in antibiotic susceptibility testing were first streaked on Luria agar plates from stocks stored at -80°C (in 20% glycerol and 80% Mueller-Hinton broth [ For the MIC experiments, the bacteria were cultured in the same medium throughout (CA-MHB or RPMIϩ) prior to the addition of antibiotics. The mid-logarithmic-phase cultures were diluted to approximately 5 ϫ 10 5 CFU (ϳOD 600 of 0.002), and 180 l was added to each experimental well of the 96-well flat-bottom plate (catalog no. 3370; Costar). Either 20 l of 1ϫ DPBS or 20 l of the desired 10ϫ drug stock was added into each culture-containing well. The plates were then incubated shaking at 100 rpm at 37°C overnight. Bacterial growth, as determined by measuring the OD 600 of each well, was determined by utilizing an Enspire Alpha multimode plate reader (PerkinElmer). To determine the MIC 90 , defined as the amount of drug required to inhibit Ն90% of the growth of the untreated controls, the density of each drug-treated well was compared to the density of the untreated control well.
Mouse studies. All animal experiments were conducted under veterinary supervision and approved by the University of California San Diego (UCSD) IACUC. Bacterial pneumonia was established as previously described (29) . In brief, S. aureus strains were grown overnight in cation-adjusted Mueller-Hinton broth (CA-MHB) and then used to inoculate fresh CA-MHB the day of the infection. Cultures were grown to logarithmic phase (ϳOD 600 of 0.4), washed three times in 1ϫ DPBS (Corning), and resuspended to a concentration of 2.5 ϫ 10 9 CFU/ml. Juvenile 8-week-old female C57Blk/6J mice were treated with 100 mg of ketamine (Koetis)/kg of body weight and 10 mg of xylazine (VetOne)/kg and then intratracheally infected with 40 l of the infection culture to give each mouse a 1 ϫ 10 8 dose using an operating otoscope (Welch Allyn). Mice were allowed to recover on a sloped heating pad and then returned to their home cage. Mice were euthanized 24 h postinfection through CO 2 exposure followed by cervical dislocation. All five lobes of the lung were removed, placed into a 2-ml sterile microtube (Sarstedt) with 1 ml of 1ϫ DPBS and 1-mm silica beads (Biospec), and homogenized for three cycles with one cycle consisting of 1 min on a MagNA lyser (Roche) followed by 1 min on ice. Homogenized samples were then serially diluted and spot plated on Luria agar (Criterion) plates, and then grown overnight at 37°C for CFU enumeration.
Whole-genome sequencing and identification of mutations. A total of 162 samples, including population and clonal samples were submitted for sequencing. Genomic DNA was isolated using Nucleospin Tissue kit (Macherey-Nagel). The resequencing library was constructed from the isolated genomic DNA using Kapa HyperPlus kit (Roche) according to the manufacturer's instructions. Then, the library was sequenced using a MiSeq reagent kit v3 (Illumina) in 600-cycle paired-end recipe on an MiSeq instrument (Illumina). Resequenced samples were then processed utilizing a modified script of the software breseq v.0.32.1 (30, 31) to map the genomes of the generated strains to the ancestral genome for identification of genetic mutations. All generated strains were mapped to S. aureus USA300_TCH1516 and reannotated using Prokka (95) (NCBI accession number GCA_000017085.1).
Data availability. Newly determined sequence data were deposited in the NCBI database under accession numbers SRX3480972 to SRX3480983 (STM), SRR10341521 to SRR10341525 (STM), SRX3482887 to SRX3482918 (STR), and SRR8552606 to SRR8552775 (SNFM and SNFR).
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